Internal medicine doctor diagnosed with Alzheimer's at 57 shares how monoclonal antibody treatment restored his cognitive ...

New treatments for neurodegenerative diseases like Alzheimer's, Parkinson's, and motor neuron disease (MND) could be unlocked thanks to microscopic medicines developed by researchers at the University ...

HHS Secretary Robert F. Kennedy Jr. appointed Michelle Branham as chair of the federal Advisory Council on Alzheimer’s ...

GLP-1 receptor agonist indications continue to expand beyond glycaemic and weight control, with benefits now shown in chronic kidney disease in type 2 diabetes, obesity-related heart failure, knee ...

A simple test could detect Alzheimer's years before symptoms appear, offering hope for earlier intervention and treatment.

Alzheimer's disease affects millions of people worldwide, yet the illness is hardest to catch at the very beginning, when new ...

Smith Could a simple blood test predict your risk of getting dementia years, or even decades, before you experience memory ...

A key Alzheimer’s drug has finally revealed its secret. Researchers discovered that lecanemab works by activating the brain’s immune cells—but only through a specific part of the antibody called the ...

The NHS spending watchdog must look again at its decision after drug manufacturers successfully appealed against Nice's ruling that the treatments were not cost-effective ...

Many Black and Latino families are navigating Alzheimer’s without access to the information, resources, and community support ...

Donanemab and lecanemab were licensed for use in the UK in 2024 but were not made available on the NHS after Nice deemed ...